{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:54:20Z","timestamp":1760550860255,"version":"3.37.3"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81621064, 81361138020"],"award-info":[{"award-number":["81621064, 81361138020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Science and Technology Projects","award":["Z141102004414065, Z151100000315029"],"award-info":[{"award-number":["Z141102004414065, Z151100000315029"]}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2016-I2M-3-014"],"award-info":[{"award-number":["2016-I2M-3-014"]}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2017-I2M-1-012"],"award-info":[{"award-number":["2017-I2M-1-012"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0217573","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T17:36:00Z","timestamp":1559842560000},"page":"e0217573","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Microdialysis combined with liquid chromatography-tandem mass spectrometry for the quantitation of gemifloxacin and its application to a muscle penetration study in healthy and MRSA-infected rats"],"prefix":"10.1371","volume":"14","author":[{"given":"Rui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Ying","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong-Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiukun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-0327","authenticated-orcid":true,"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Fu","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4274\/tjps.04934","article-title":"A Validated Reverse Phase-Ultra-Performance Liquid Chromatography Method for the Determination of Gemifloxacin Mesylate in Bulk and its Pharmaceutical Preparation","volume":"16","year":"2019","journal-title":"Turk J Pharm Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2016.06.026","article-title":"Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus","volume":"48","author":"A Marino","year":"2016","journal-title":"Int. J. Antimicrob Agents"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40262-014-0131-8","article-title":"Role of microdialysis in pharmacokinetics and pharmacodynamics: current status and future directions","volume":"53","author":"FJ Azeredo","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2011.04080.x","article-title":"Therapeutic drug monitoring of antimicrobials","volume":"73","author":"JA Roberts","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1592\/phco.2006.26.1.129","article-title":"Monte Carlo simulation in the evaluation of susceptibility breakpoints: predicting the future: insights from the society of infectious diseases pharmacists","volume":"26","author":"PG Ambrose","year":"2006","journal-title":"Pharmacotherapy"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkm476","article-title":"Tissue concentrations: do we ever learn?","volume":"61","author":"JW Mouton","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/0091270006299091","article-title":"AAPS-FDA workshop white paper: microdialysis principles, application, and regulatory perspectives","volume":"47","author":"CS Chaurasia","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.48.5.1441-1453.2004","article-title":"Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue","volume":"48","author":"M Muller","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/378809","article-title":"Gatifloxacin, gemifloxacin and moxifloxacin: the role of 3 newer fluoroquinolones","volume":"37","author":"LD Saravolatz","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1128\/AAC.48.11.4246-4249.2004","article-title":"Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose","volume":"48","author":"F Islinger","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1128\/AAC.48.9.3419-3424.2004","article-title":"Effect of ertapenem protein binding on killing of bacteria","volume":"48","author":"DE Nix","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00134-008-1122-8","article-title":"The impact of perioperative atelectasis on antibiotic penetration into lung tissue: an in vivo microdialysis study","volume":"34","author":"D Hutschala","year":"2008","journal-title":"Intensive Care Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1367-5931(00)00106-X","article-title":"New approaches in the treatment of bacterial infections","volume":"4","author":"K Bush","year":"2000","journal-title":"Curr Opin Chem Biol"},{"year":"2013","key":"ref14","article-title":"Guidance for Industry: Bioanalytical Method Validation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2008.02.023","article-title":"Evaluation of gatifloxacin penetration into skeletal muscle and lung by microdialysis in rats","volume":"358","author":"L Tasso","year":"2008","journal-title":"Int J Pharm"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jchromb.2013.01.006","article-title":"Validation of an efficient LC-microdialysis method for gemifloxacin quantitation in lung, kidney and liver of rats","volume":"920","author":"BV de Ara\u00fajo","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tox.2007.05.005","article-title":"Estimation of proinflammatory biomarkers of skin irritation by dermal microdialysis following exposure with irritant chemicals","volume":"237","author":"SV Fulzele","year":"2007","journal-title":"Toxicology"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/s0102-865020170106","article-title":"Oxacillin magnetically targeted for the treatment of Methicillin-Resistant <italic>S<\/italic>. <italic>aureus<\/italic> infection in rats","volume":"32","author":"JF Carvalho","year":"2017","journal-title":"Acta Cir Bras"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1179\/1973947812Y.0000000061","article-title":"Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model","volume":"25","author":"MA Banevicius","year":"2013","journal-title":"J Chemother"},{"key":"ref20","first-page":"27","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically\u201411th edition","year":"2012","journal-title":"Approved standard M07-A10"},{"key":"ref21","first-page":"435","article-title":"The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs","volume":"29","author":"JV Ramji","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1016\/j.jchromb.2011.09.011","article-title":"Reversed phase liquid chromatography method with fluorescence detection of gemifloxacin in rat plasma and its application to the pharmacokinetic study","volume":"879","author":"M Kaiser","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2133\/dmpk.17.237","article-title":"Muscle distribution of antimicrobial agents after a single intravenous administration to rats","volume":"17","author":"H Araki","year":"2002","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1128\/AAC.43.5.1307","article-title":"Distribution and antimicrobial activity of ciprofloxacin in human soft tissues","volume":"43","author":"M Brunner","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","article-title":"Penetration of moxifloxacin into peripheral compartments in humans","volume":"43","author":"M Muller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpba.2016.10.023","article-title":"Application of a LC-MS\/MS method for evaluating lung penetration of tobramycin in rats by microdialysis","volume":"134","author":"PM Bernardi","year":"2017","journal-title":"J Pharm Biome Anal"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/17425255.4.10.1245","article-title":"A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain","volume":"4","author":"DJ Roberts","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/00498254.2012.720740","article-title":"Transport of gemifloxacin, a 4<sup>th<\/sup> generateon quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug","volume":"43","author":"HE Jin","year":"2013","journal-title":"Xenobiotica"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2146\/ajhp110464","article-title":"Declining susceptibilities of gram-negative bacteria to the fluoroquinolones: effects on pharmacokinetics, pharmacodynamics, and clinical outcomes","volume":"69","author":"MJ Labreche","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jop.2011.0072","article-title":"Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones","volume":"28","author":"J Segreti","year":"2012","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0217573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:58:33Z","timestamp":1588967913000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0217573"}},"subtitle":[],"editor":[{"given":"Hua","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0217573","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,6,6]]}}}